Combined treatment of iron depletion and IgG antibody
US5762932A · kind A · utility
6Cited by
6References
1Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Sep 20, 1996 |
| Grant date | Jun 9, 1998 |
| Priority date | — |
| Expiry date | Sep 20, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K39/39558
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of inhibiting tumor growth includes the steps of depleting intracellular iron levels of tumor cells to increase expression of cellular transferrin receptors in tumor cells and then exposing the tumor cells to monoclonal IgG anti-transferrin receptor antibodies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.